Table 6: Effect of high and low proBNP in Group C: participants with atrial fibrillation
Univariate Logistic Regression Univariate Logistic Regression Univariate Logistic Regression
p-value HR (CI)
Case pos/neg
PACS (%) 11/61 0.004 1.14 (1.04-1.25)
ACS (%) 11/61 0.151 1.04 (0.98-1.11)
ATS (%) 11/61 0.022 0.95 (0.91-0.98)
Atrial SR S (1/s) 11/61 0.017 0.33 (0.14-0.82)
Atrial SR E (1/s) 11/61 0.178 1.79 (0.77-4.15)
Atrial SR A (1/s) 11/61 0.004 2.83 (1.40-5.71)
LASI (1/%) 11/59 0.004 0.95 (0.92-0.95)
MV E(cm/s) 11/59 0.123 5.24 (0.64-42.91)
MV A (cm/s) 11/59 0.459
MV E/A (1/1) 8/59 0.013 4.30 (1.370-13.45)
MV DT (ms) 11/59 0.633
E/e´ 11/59 0.392
LA volume index (ml/m2) 11/61 0.017 1.06 (1.01-1.11)
TAPSE (cm) 11/60 0.030 0.21 (0.05-0.86)
TR PG median (mmHg)‡ 9/57 0.092 1.06 (0.99-1.14)
Velocity Basal Septal E (cm/s) 11/61 0.645
Velocity Basal Lateral E (cm/s) 11/61 0.809
Velocity Basal Septal A (cm/s) 11/61 0.043 1.26 (1.01-1.59)
Velocity Basal Lateral A (cm/s) 11/61 0.055 1.25 (0.995-1.57)
LV Stoke Volume (ml) 11/61 0.600
LV EF (%) 10/54 0.034 0.92 (0.84-0.99)
LV EDV (ml) 10/61 0.359
LV ESV (ml) 10/61 0.153 1.01 (0.995-1.03)
LV mass Index (g/m2) 11/60 0.664
LV ES long Strain (%) 7/52 0.389 1.07 (0.92-1.25)
LV PL SR S (1/s) 7/52 0.717
LV PL SR E (1/s) 7/52 0.945
LV PL SR A (1/s) 7/52 0.062 0.07 (0.004-1.15)
PACS: peak atrial contraction strain; ACS: atrial conduit strain; ATS: atrial total strain; SR: strain rate; S: during systole; E: during early filling phase; A: during atrial contraction; LASI: left atrial stiffness index (E/E´ /LA strain); MV: mitral valve; DT: deceleration time; LA: left atrium; TAPSE: tricuspid annular plane systolic excursion; TR PG: tricuspid regurgitation peak gradient; LV: left ventricle; EF: ejection fraction; EDV: end diastolic volume; ESV: end systolic volume; ES end systolic; PL: peak longitudinal Patients had atrial fibrillation defined by Hx or ECG PACS: peak atrial contraction strain; ACS: atrial conduit strain; ATS: atrial total strain; SR: strain rate; S: during systole; E: during early filling phase; A: during atrial contraction; LASI: left atrial stiffness index (E/E´ /LA strain); MV: mitral valve; DT: deceleration time; LA: left atrium; TAPSE: tricuspid annular plane systolic excursion; TR PG: tricuspid regurgitation peak gradient; LV: left ventricle; EF: ejection fraction; EDV: end diastolic volume; ESV: end systolic volume; ES end systolic; PL: peak longitudinal Patients had atrial fibrillation defined by Hx or ECG PACS: peak atrial contraction strain; ACS: atrial conduit strain; ATS: atrial total strain; SR: strain rate; S: during systole; E: during early filling phase; A: during atrial contraction; LASI: left atrial stiffness index (E/E´ /LA strain); MV: mitral valve; DT: deceleration time; LA: left atrium; TAPSE: tricuspid annular plane systolic excursion; TR PG: tricuspid regurgitation peak gradient; LV: left ventricle; EF: ejection fraction; EDV: end diastolic volume; ESV: end systolic volume; ES end systolic; PL: peak longitudinal Patients had atrial fibrillation defined by Hx or ECG PACS: peak atrial contraction strain; ACS: atrial conduit strain; ATS: atrial total strain; SR: strain rate; S: during systole; E: during early filling phase; A: during atrial contraction; LASI: left atrial stiffness index (E/E´ /LA strain); MV: mitral valve; DT: deceleration time; LA: left atrium; TAPSE: tricuspid annular plane systolic excursion; TR PG: tricuspid regurgitation peak gradient; LV: left ventricle; EF: ejection fraction; EDV: end diastolic volume; ESV: end systolic volume; ES end systolic; PL: peak longitudinal Patients had atrial fibrillation defined by Hx or ECG